Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of ag
It is not known at what age lung function impairment may arise in children with cystic fibrosis (CF)...
It is not known at what age lung function impairment may arise in children with cystic fibrosis (CF)...
Introduction and objectives Progressive respiratory disease accounts for most of the mortality and m...
Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn sc...
Background Newborn screening allows novel treatments for cystic fibrosis (CF) to be trialled in earl...
BACKGROUND: Newborn screening allows novel treatments for cystic fibrosis (CF) to be trialled in ear...
Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn sc...
Background Newborn screening allows novel treatments for cystic fibrosis (CF) to be trialled in earl...
Rationale: The promise of newborn screening (NBS) for cystic fibrosis (CF) has not been fully realiz...
The onset of lung disease in cystic fibrosis (CF) begins early in life with respiratory infection, i...
The onset of lung disease in cystic fibrosis (CF) begins early in life with respiratory infection, i...
It is not known at what age lung function impairment may arise in children with cystic fibrosis (CF)...
It is not known at what age lung function impairment may arise in children with cystic fibrosis (CF)...
Objectives: To determine the prevalence of bronchiectasis in young children with cystic fibrosis (CF...
It is not known at what age lung function impairment may arise in children with cystic fibrosis (CF)...
It is not known at what age lung function impairment may arise in children with cystic fibrosis (CF)...
It is not known at what age lung function impairment may arise in children with cystic fibrosis (CF)...
Introduction and objectives Progressive respiratory disease accounts for most of the mortality and m...
Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn sc...
Background Newborn screening allows novel treatments for cystic fibrosis (CF) to be trialled in earl...
BACKGROUND: Newborn screening allows novel treatments for cystic fibrosis (CF) to be trialled in ear...
Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn sc...
Background Newborn screening allows novel treatments for cystic fibrosis (CF) to be trialled in earl...
Rationale: The promise of newborn screening (NBS) for cystic fibrosis (CF) has not been fully realiz...
The onset of lung disease in cystic fibrosis (CF) begins early in life with respiratory infection, i...
The onset of lung disease in cystic fibrosis (CF) begins early in life with respiratory infection, i...
It is not known at what age lung function impairment may arise in children with cystic fibrosis (CF)...
It is not known at what age lung function impairment may arise in children with cystic fibrosis (CF)...
Objectives: To determine the prevalence of bronchiectasis in young children with cystic fibrosis (CF...
It is not known at what age lung function impairment may arise in children with cystic fibrosis (CF)...
It is not known at what age lung function impairment may arise in children with cystic fibrosis (CF)...
It is not known at what age lung function impairment may arise in children with cystic fibrosis (CF)...
Introduction and objectives Progressive respiratory disease accounts for most of the mortality and m...